Bupropion Hydrochloride
- Product NDC
- 70518-0859
- 11-digit product format
- 705180859
- Labeler code
- 70518
- Product ID
- 70518-0859_e283039d-4f66-22b4-e053-2995a90a4774
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090693
- Marketing category
- ANDA
- Marketing start
- 2017-11-20
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-0859 | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] | 15 | Legacy NDC | 20250503_15fe05b6-de2e-4b95-876f-30226a9b60f1.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0859-0 | 70518085900 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-0859-0) | 2017-11-20 | 0000-00-00 | No | No | Current |